• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《东地中海区域国家结直肠癌生存率:系统评价和荟萃分析》

Survival Rate of Colorectal Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis.

机构信息

Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.

出版信息

Cancer Control. 2020 Jan-Dec;27(1):1073274820964146. doi: 10.1177/1073274820964146.

DOI:10.1177/1073274820964146
PMID:33074714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7791530/
Abstract

Colorectal cancer (CRC) is the second most common cause of cancer-related deaths worldwide. Survival rates are among the most important factors in quality control and assessment of treatment protocols. This study was aimed to assess the survival rate of colorectal cancer in Eastern Mediterranean Region Countries. In the present study we comprehensively searched 6 international databases including PubMed/Medline, ProQuest, Scopus, Embase, Web of Knowledge and Google Scholar for published articles until November 2018. The Newcastle-Ottawa Quality Assessment Form for Cohort Studies was applied to evaluate the quality of included studies. The heterogeneity of papers was assessed with the Cochran Test and I-Square statistics. Meta-regression test was performed based on publication year, sample size and Human Development Index (HDI) of each study. Among the total of 1023 titles found in the systematic search, 43 studies were eligible to be included in the present meta-analysis. According to the results, the 1-year, 3-year and 5-year survival rate of patients with Colorectal Cancer was 88.07% (95% CI, 83.22-92.92), 70.67% (95% CI, 66.40-74.93) and, 57.26% (95% CI, 50.43-64.10); respectively. Furthermore, Meta-regressions did not show significant correlations between survival rate and year, sample size or Human Development Index. Survival rates, especially the 5-year survival rate in the EMRO were less than European countries and the USA. Documented and comprehensive evidence-based findings of the present meta-analysis can be used to enhance policies and outcomes of different medical areas including prophylaxis, treatment and health related objectives in colorectal cancer.

摘要

结直肠癌(CRC)是全球癌症相关死亡的第二大主要原因。生存率是质量控制和评估治疗方案的最重要因素之一。本研究旨在评估中东地中海地区国家结直肠癌的生存率。在本研究中,我们全面检索了 6 个国际数据库,包括 PubMed/Medline、ProQuest、Scopus、Embase、Web of Knowledge 和 Google Scholar,以获取截至 2018 年 11 月发表的文章。采用纽卡斯尔-渥太华队列研究质量评估表评估纳入研究的质量。使用 Cochran 检验和 I-Square 统计量评估论文的异质性。根据每项研究的发表年份、样本量和人类发展指数(HDI)进行元回归检验。在系统搜索中总共发现了 1023 个标题,其中 43 项研究符合纳入本荟萃分析的条件。根据结果,结直肠癌患者的 1 年、3 年和 5 年生存率分别为 88.07%(95%CI,83.22-92.92)、70.67%(95%CI,66.40-74.93)和 57.26%(95%CI,50.43-64.10)。此外,元回归分析未显示生存率与年份、样本量或人类发展指数之间存在显著相关性。生存率,尤其是 EMRO 地区的 5 年生存率,低于欧洲国家和美国。本荟萃分析的有文件记载和基于证据的结果可用于加强包括预防、治疗和与结直肠癌相关的健康目标在内的不同医学领域的政策和结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/b85635005c36/10.1177_1073274820964146-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/df05c88d20c1/10.1177_1073274820964146-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/04ceb9bdb45f/10.1177_1073274820964146-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/73500a83430a/10.1177_1073274820964146-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/f3f633ee13f9/10.1177_1073274820964146-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/b6e5bd3d130c/10.1177_1073274820964146-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/b85635005c36/10.1177_1073274820964146-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/df05c88d20c1/10.1177_1073274820964146-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/04ceb9bdb45f/10.1177_1073274820964146-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/73500a83430a/10.1177_1073274820964146-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/f3f633ee13f9/10.1177_1073274820964146-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/b6e5bd3d130c/10.1177_1073274820964146-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fcf1/7791530/b85635005c36/10.1177_1073274820964146-fig6.jpg

相似文献

1
Survival Rate of Colorectal Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis.《东地中海区域国家结直肠癌生存率:系统评价和荟萃分析》
Cancer Control. 2020 Jan-Dec;27(1):1073274820964146. doi: 10.1177/1073274820964146.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Association between smoking and colorectal cancer in Eastern Mediterranean Regional Office (EMRO): A systematic review and meta-analysis.吸烟与东地中海区域办事处(EMRO)结直肠癌的关系:系统评价和荟萃分析。
Saudi J Gastroenterol. 2023 Jul-Aug;29(4):204-211. doi: 10.4103/sjg.sjg_163_23.
4
Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis.埃塞俄比亚结直肠癌患者的死亡率及其预测因素:系统评价和荟萃分析。
BMC Cancer. 2024 Jul 10;24(1):821. doi: 10.1186/s12885-024-12597-9.
5
Survival Rate of Breast Cancer in Eastern Mediterranean Region Countries: A Systematic Review and Meta-Analysis.《东地中海区域国家乳腺癌生存率:系统评价和荟萃分析》。
Ann Glob Health. 2019 Dec 4;85(1):138. doi: 10.5334/aogh.2521.
6
Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis.伊朗结直肠癌的生存率:系统评价与荟萃分析
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):13-21. doi: 10.31557/APJCP.2019.20.1.13.
7
The prevalence of undiagnosed type 2 diabetes and prediabetes in Eastern Mediterranean region (EMRO): A systematic review and meta-analysis.东地中海地区(EMRO)未确诊 2 型糖尿病和糖尿病前期的患病率:系统评价和荟萃分析。
Diabetes Res Clin Pract. 2020 Feb;160:107931. doi: 10.1016/j.diabres.2019.107931. Epub 2019 Nov 30.
8
The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and meta-analysis.亚洲国家肝细胞癌的生存率:一项系统评价与荟萃分析。
EXCLI J. 2020 Jan 13;19:108-130. doi: 10.17179/excli2019-1842. eCollection 2020.
9
Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study.亚洲国家甲状腺癌的生存率:一项系统评价和荟萃分析研究。
Endocrine. 2023 Nov;82(2):237-249. doi: 10.1007/s12020-023-03408-5. Epub 2023 Jun 3.
10
Survival rate of ovarian cancer in Asian countries: a systematic review and meta-analysis.亚洲国家卵巢癌的存活率:系统评价和荟萃分析。
BMC Cancer. 2023 Jun 16;23(1):558. doi: 10.1186/s12885-023-11041-8.

引用本文的文献

1
Five-year survival rate of kidney cancer (localized renal cell carcinoma) in the Asia: A systematic review and meta-analysis.亚洲肾癌(局限性肾细胞癌)的五年生存率:一项系统评价和荟萃分析。
Medicine (Baltimore). 2025 Aug 22;104(34):e43867. doi: 10.1097/MD.0000000000043867.
2
Mapping the colorectal cancer patient journey in Egypt: A qualitative study of diagnosis, treatment, and lifestyle perspectives.描绘埃及结直肠癌患者的就医历程:一项关于诊断、治疗及生活方式观点的定性研究
PLoS One. 2025 Jul 2;20(7):e0326144. doi: 10.1371/journal.pone.0326144. eCollection 2025.
3
Mortality rate and predictors of colorectal cancer patients in Ethiopia: a systematic review and meta-analysis.

本文引用的文献

1
The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.195 个国家和地区 1990-2017 年的全球、区域和国家结直肠癌发病和死亡负担及其归因风险因素:基于 2017 年全球疾病负担研究的系统分析
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):913-933. doi: 10.1016/S2468-1253(19)30345-0. Epub 2019 Oct 21.
2
Scientific Evidence for Cancer Control in Vietnam.越南癌症防控的科学证据。
Cancer Control. 2019 Jan-Dec;26(1):1073274819866450. doi: 10.1177/1073274819866450.
3
Familial and non-familial risk factors associated with colorectal cancer survival in young and middle-aged patients.
埃塞俄比亚结直肠癌患者的死亡率及其预测因素:系统评价和荟萃分析。
BMC Cancer. 2024 Jul 10;24(1):821. doi: 10.1186/s12885-024-12597-9.
4
Risk factors affecting patients survival with colorectal cancer in Morocco: survival analysis using an interpretable machine learning approach.影响摩洛哥结直肠癌患者生存的风险因素:使用可解释机器学习方法的生存分析。
Sci Rep. 2024 Feb 12;14(1):3556. doi: 10.1038/s41598-024-51304-3.
5
Family history of cancer as a potential risk factor for colorectal cancer in EMRO countries: a systematic review and meta-analysis.家族癌症史作为 EMRO 国家结直肠癌潜在风险因素的系统评价和荟萃分析。
Sci Rep. 2023 Oct 14;13(1):17457. doi: 10.1038/s41598-023-44487-8.
6
Impact of interventions on the quality of life of cancer patients: a systematic review and meta-analysis of longitudinal research.干预措施对癌症患者生活质量的影响:一项基于纵向研究的系统评价和荟萃分析。
Health Qual Life Outcomes. 2023 Oct 11;21(1):112. doi: 10.1186/s12955-023-02189-9.
7
Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study.亚洲国家甲状腺癌的生存率:一项系统评价和荟萃分析研究。
Endocrine. 2023 Nov;82(2):237-249. doi: 10.1007/s12020-023-03408-5. Epub 2023 Jun 3.
8
Early Onset Colorectal Cancer in Arabs, Are We Dealing with a Distinct Disease?阿拉伯人中的早发性结直肠癌,我们面对的是一种独特的疾病吗?
Cancers (Basel). 2023 Jan 31;15(3):889. doi: 10.3390/cancers15030889.
9
New Insights Into the Anticancer Effects of -Coumaric Acid: Focus on Colorectal Cancer.对香豆酸抗癌作用的新见解:聚焦于结直肠癌
Dose Response. 2023 Jan 4;21(1):15593258221150704. doi: 10.1177/15593258221150704. eCollection 2023 Jan-Mar.
10
Overall Survival Rate of Vietnamese Patients with Colorectal Cancer: A Hospital-Based Cohort Study in the Central Region of Vietnam.越南结直肠癌患者的总生存率:越南中部地区以医院为基础的队列研究。
Asian Pac J Cancer Prev. 2021 Nov 1;22(11):3569-3575. doi: 10.31557/APJCP.2021.22.11.3569.
家族和非家族风险因素与中青年结直肠癌患者的生存相关。
Int J Colorectal Dis. 2019 Oct;34(10):1673-1680. doi: 10.1007/s00384-019-03380-5. Epub 2019 Aug 30.
4
Prevalence of Depression and Anxiety in Colorectal Cancer Patients: A Literature Review.结直肠癌患者的抑郁和焦虑患病率:文献综述。
Int J Environ Res Public Health. 2019 Jan 31;16(3):411. doi: 10.3390/ijerph16030411.
5
Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis.伊朗结直肠癌的生存率:系统评价与荟萃分析
Asian Pac J Cancer Prev. 2019 Jan 25;20(1):13-21. doi: 10.31557/APJCP.2019.20.1.13.
6
Trends in Mortality Rates for Gastrointestinal Cancers in Fars Province, Iran (2005-2015).伊朗法尔斯省胃肠道癌症死亡率趋势(2005 - 2015年)
J Gastrointest Cancer. 2020 Mar;51(1):63-69. doi: 10.1007/s12029-019-00204-1.
7
Determining the Survival Rate of Colorectal Cancer in Iran: A Systematic Review and Meta-Analysis.确定伊朗结直肠癌的生存率:一项系统评价与荟萃分析
Asian Pac J Cancer Prev. 2018 Nov 28;19(11):3009-3018. doi: 10.31557/APJCP.2018.19.11.3009.
8
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
9
Sixteen Years of Experience with the Treatment of Advanced Colorectal Cancer in Iran; A Report from Three Institutions.伊朗治疗晚期结直肠癌十六年经验;来自三家机构的报告。
Middle East J Dig Dis. 2018 Jul;10(3):160-168. doi: 10.15171/mejdd.2018.105. Epub 2018 May 27.
10
Effects of screening and universal healthcare on long-term colorectal cancer mortality.筛查和全民医保对长期结直肠癌死亡率的影响。
Int J Epidemiol. 2019 Apr 1;48(2):538-548. doi: 10.1093/ije/dyy182.